May 25, 2022CorporateTerumo Blood and Cell Technologies Inaugurates Second Manufacturing Facility in Colorado
May 17, 2022CorporateTerumo Pharmaceutical Solutions Offers Pre-Fillable Syringe Solutions for Demanding Low Dose Applications Such as Ophthalmic
May 16, 2022CorporateTerumo Announces Change in Indication for Dexcom G6 CGM System in Japan Adjunctive use of Blood Glucose Meter Principally Not Required
Refining Searches 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Corporate Financial November 05, 2015 Financial Terumo Revises Upward Interim Dividend and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2016 (PDF 17.28 KB) September 24, 2015 Financial Revision to First-Half and Full-Year Results Forecast for FY2015 (PDF 59.8 KB) September 18, 2015 Corporate Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan September 09, 2015 Corporate Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field September 02, 2015 Corporate Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare August 12, 2015 Financial Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 63.66 KB) August 11, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 21.89 KB) August 10, 2015 Corporate Terumo Receives Approval for the Manufacturer and Sale of its Ultimaster Drug-Eluting Coronary Stent in Japan August 07, 2015 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB) August 04, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB) June 24, 2015 Financial Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 67.88 KB) May 28, 2015 Corporate Terumo to Support Relief Efforts Following Nepal Earthquake May 19, 2015 Corporate Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART) May 08, 2015 Corporate Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB) May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB) April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB) April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB) April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA) April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology March 27, 2015 Corporate FAMHP advises patients to not suspend nor stop any treatments March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB) Pagination Previous page ‹ Current page1 Next page ›
November 05, 2015 Financial Terumo Revises Upward Interim Dividend and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2016 (PDF 17.28 KB)
September 24, 2015 Financial Revision to First-Half and Full-Year Results Forecast for FY2015 (PDF 59.8 KB)
September 18, 2015 Corporate Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan
September 09, 2015 Corporate Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field
September 02, 2015 Corporate Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare
August 12, 2015 Financial Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 63.66 KB)
August 11, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 21.89 KB)
August 10, 2015 Corporate Terumo Receives Approval for the Manufacturer and Sale of its Ultimaster Drug-Eluting Coronary Stent in Japan
August 07, 2015 Financial Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB)
August 04, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB)
June 24, 2015 Financial Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 67.88 KB)
May 19, 2015 Corporate Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART)
May 08, 2015 Corporate Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB)
May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)
April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)
April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)
April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine
April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology
March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients
February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area
February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)